
Keytruda
Productby Merck & Co., Inc.
Heard in 13 episodes across 10 shows since Aug 2026
Keytruda is the brand name for pembrolizumab, a humanized monoclonal antibody and programmed cell death protein 1 (PD-1) immune-checkpoint inhibitor. It is used in cancer immunotherapy for many types of cancer and is administered by slow intravenous injection.
Episodes
13
across 10 shows
First heard
Aug 2026
Episodes per month
Public PodLume episodes featuring it, over the last year.
9
4
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 9 |
| Sep 2026 | 4 |
| Oct 2026 | 0 |
Episodes
13 episodes featuring Keytruda, newest first
- Sep 30, 2026
Bongino links election stakes to COVID-era medical distrustThe Dan Bongino ShowSep 30, 2026 - Sep 13, 2026
Biotech’s rally tests the promise of cancer breakthroughsWSJ's Take On the WeekSep 13, 2026 - Sep 3, 2026
Personalized vaccines target melanoma’s returnScience FridaySep 3, 2026 - Sep 2, 2026
Moderna turns tumor mutations into personalized cancer vaccinesThe a16z ShowSep 2, 2026 - Aug 28, 2026
Moderna bets cancer vaccine can outlast its COVID boomThe Journal.Aug 28, 2026 - Aug 23, 2026
Moderna’s melanoma vaccine tests biotech optimismEquity Mates Investing PodcastAug 23, 2026